162 related articles for article (PubMed ID: 16651629)
1. Expression and oncogenic role of Brk (PTK6/Sik) protein tyrosine kinase in lymphocytes.
Kasprzycka M; Majewski M; Wang ZJ; Ptasznik A; Wysocka M; Zhang Q; Marzec M; Gimotty P; Crompton MR; Wasik MA
Am J Pathol; 2006 May; 168(5):1631-41. PubMed ID: 16651629
[TBL] [Abstract][Full Text] [Related]
2. Signal transducer and activator of transcription 5b: a new target of breast tumor kinase/protein tyrosine kinase 6.
Weaver AM; Silva CM
Breast Cancer Res; 2007; 9(6):R79. PubMed ID: 17997837
[TBL] [Abstract][Full Text] [Related]
3. Brk/PTK6 sustains activated EGFR signaling through inhibiting EGFR degradation and transactivating EGFR.
Li X; Lu Y; Liang K; Hsu JM; Albarracin C; Mills GB; Hung MC; Fan Z
Oncogene; 2012 Oct; 31(40):4372-83. PubMed ID: 22231447
[TBL] [Abstract][Full Text] [Related]
4. Breast tumor kinase/protein tyrosine kinase 6 (Brk/PTK6) activity in normal and neoplastic biliary epithelia.
Mizuguchi Y; Specht S; Isse K; Sasatomi E; Lunz JG; Takizawa T; Demetris AJ
J Hepatol; 2015 Aug; 63(2):399-407. PubMed ID: 25770659
[TBL] [Abstract][Full Text] [Related]
5. Role of breast tumour kinase in the in vitro differentiation of HaCaT cells.
Wang TC; Jee SH; Tsai TF; Huang YL; Tsai WL; Chen RH
Br J Dermatol; 2005 Aug; 153(2):282-9. PubMed ID: 16086737
[TBL] [Abstract][Full Text] [Related]
6. Brk/PTK6 signaling in normal and cancer cell models.
Ostrander JH; Daniel AR; Lange CA
Curr Opin Pharmacol; 2010 Dec; 10(6):662-9. PubMed ID: 20832360
[TBL] [Abstract][Full Text] [Related]
7. Brk/PTK6 cooperates with HER2 and Src in regulating breast cancer cell survival and epithelial-to-mesenchymal transition.
Ai M; Liang K; Lu Y; Qiu S; Fan Z
Cancer Biol Ther; 2013 Mar; 14(3):237-45. PubMed ID: 23291984
[TBL] [Abstract][Full Text] [Related]
8. The nuclear tyrosine kinase BRK/Sik phosphorylates and inhibits the RNA-binding activities of the Sam68-like mammalian proteins SLM-1 and SLM-2.
Haegebarth A; Heap D; Bie W; Derry JJ; Richard S; Tyner AL
J Biol Chem; 2004 Dec; 279(52):54398-404. PubMed ID: 15471878
[TBL] [Abstract][Full Text] [Related]
9. Tyrosine phosphorylation of sam68 by breast tumor kinase regulates intranuclear localization and cell cycle progression.
Lukong KE; Larocque D; Tyner AL; Richard S
J Biol Chem; 2005 Nov; 280(46):38639-47. PubMed ID: 16179349
[TBL] [Abstract][Full Text] [Related]
10. Breast tumor kinase (protein tyrosine kinase 6) regulates heregulin-induced activation of ERK5 and p38 MAP kinases in breast cancer cells.
Ostrander JH; Daniel AR; Lofgren K; Kleer CG; Lange CA
Cancer Res; 2007 May; 67(9):4199-209. PubMed ID: 17483331
[TBL] [Abstract][Full Text] [Related]
11. STAP-2 is phosphorylated at tyrosine-250 by Brk and modulates Brk-mediated STAT3 activation.
Ikeda O; Miyasaka Y; Sekine Y; Mizushima A; Muromoto R; Nanbo A; Yoshimura A; Matsuda T
Biochem Biophys Res Commun; 2009 Jun; 384(1):71-5. PubMed ID: 19393627
[TBL] [Abstract][Full Text] [Related]
12. HER2 regulates Brk/PTK6 stability via upregulating calpastatin, an inhibitor of calpain.
Ai M; Qiu S; Lu Y; Fan Z
Cell Signal; 2013 Sep; 25(9):1754-61. PubMed ID: 23707532
[TBL] [Abstract][Full Text] [Related]
13. Protein-tyrosine phosphatase 1B antagonized signaling by insulin-like growth factor-1 receptor and kinase BRK/PTK6 in ovarian cancer cells.
Fan G; Lin G; Lucito R; Tonks NK
J Biol Chem; 2013 Aug; 288(34):24923-34. PubMed ID: 23814047
[TBL] [Abstract][Full Text] [Related]
14. Cancer-Associated Mutations in Breast Tumor Kinase/PTK6 Differentially Affect Enzyme Activity and Substrate Recognition.
Tsui T; Miller WT
Biochemistry; 2015 May; 54(20):3173-82. PubMed ID: 25940761
[TBL] [Abstract][Full Text] [Related]
15. BRK phosphorylates PSF promoting its cytoplasmic localization and cell cycle arrest.
Lukong KE; Huot ME; Richard S
Cell Signal; 2009 Sep; 21(9):1415-22. PubMed ID: 19439179
[TBL] [Abstract][Full Text] [Related]
16. Breast tumor kinase (Brk/PTK6) plays a role in the differentiation of primary keratinocytes.
Tupper J; Crompton MR; Harvey AJ
Arch Dermatol Res; 2011 May; 303(4):293-7. PubMed ID: 21240512
[TBL] [Abstract][Full Text] [Related]
17. BRK targets Dok1 for ubiquitin-mediated proteasomal degradation to promote cell proliferation and migration.
Miah S; Goel RK; Dai C; Kalra N; Beaton-Brown E; Bagu ET; Bonham K; Lukong KE
PLoS One; 2014; 9(2):e87684. PubMed ID: 24523872
[TBL] [Abstract][Full Text] [Related]
18. Building a better understanding of the intracellular tyrosine kinase PTK6 - BRK by BRK.
Brauer PM; Tyner AL
Biochim Biophys Acta; 2010 Aug; 1806(1):66-73. PubMed ID: 20193745
[TBL] [Abstract][Full Text] [Related]
19. Interactions of STAP-2 with Brk and STAT3 participate in cell growth of human breast cancer cells.
Ikeda O; Sekine Y; Mizushima A; Nakasuji M; Miyasaka Y; Yamamoto C; Muromoto R; Nanbo A; Oritani K; Yoshimura A; Matsuda T
J Biol Chem; 2010 Dec; 285(49):38093-103. PubMed ID: 20929863
[TBL] [Abstract][Full Text] [Related]
20. Breast Tumor Kinase (Brk/PTK6) Is Induced by HIF, Glucocorticoid Receptor, and PELP1-Mediated Stress Signaling in Triple-Negative Breast Cancer.
Regan Anderson TM; Ma SH; Raj GV; Cidlowski JA; Helle TM; Knutson TP; Krutilina RI; Seagroves TN; Lange CA
Cancer Res; 2016 Mar; 76(6):1653-63. PubMed ID: 26825173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
